Latest filing published 09 Oct 2026 for CF PharmTech, Inc. - H Shares, €15k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -77.6%Entry HK$23.00 · Close 06 Nov 2026 HK$5.16
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
LIANG Bill Wenqing: trading record in brief
LIANG Bill Wenqing (chief executive) discloses dealings in CF PharmTech, Inc. - H Shares to HKEX. The record holds 3 filings, for trades running from 1 April 2026 to 6 October 2026.
On the market, this insider has only ever bought: 3 purchases, €57k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
Half of the purchases are above €20k and half below. Measured against the company's value, the median purchase equals 0.0029% of market capitalisation, across 3 purchases where it is known. 2 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The latest filing, published on 9 October 2026, reports an open-market purchase of €15k in CF PharmTech, Inc. - H Shares. Typically, a trade is published a median of 4 days after it takes place. This delay matters because a trade only becomes useful information once it is public. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.
Companies and markets linked to LIANG Bill Wenqing
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 19,300 shares@ HK$6.92160.0021% mcap26.6% of flowShareXHKGHKEX:DA20261008E00529Canonical exit: 4 Jan 2027 (T+90)
- 25,100 shares@ HK$7.29160.0029% mcap49.0% of flowShareXHKGHKEX:DA20261002E00436Canonical exit: 27 Dec 2026 (T+90)
- 8,500 shares@ HK$22.78240.0031% mcap100.0% of flowShareXHKGHKEX:DA20260408E00585Canonical exit: 30 Jun 2026 (T+90)
3 of 1 declaration